| Structure |
Chemical Name |
CAS |
MF |
 |
3-(1-アジリジニル)プロピルアミン |
1072-65-7 |
C5H12N2 |
 |
3,5-ジ(4-ピリジニル)-1H-1,2,4-トリアゾール-1-アミン |
4923-06-2 |
C12H10N6 |
![(1α,2β,4β,5α)-9-メチル-3-オキサ-9-アザトリシクロ[3.3.1.02,4]ノナン-7α-オール](/CAS/20180808/GIF/498-46-4.gif) |
(1α,2β,4β,5α)-9-メチル-3-オキサ-9-アザトリシクロ[3.3.1.02,4]ノナン-7α-オール |
498-46-4 |
C8H13NO2 |
![(1α,4β)-4-[[6,8-ジブロモ-1,4-ジヒドロキナゾリン]-3(2H)-イル]シクロヘキサノール](/CAS/GIF/18683-95-9.gif) |
(1α,4β)-4-[[6,8-ジブロモ-1,4-ジヒドロキナゾリン]-3(2H)-イル]シクロヘキサノール |
18683-95-9 |
C14H18Br2N2O |
 |
16-ヒドロキシエリスロマイシン |
82230-93-1 |
C37H67NO14 |
![4-[1-(4-クロロフェニル)-1-フェニルエトキシ]-1-メチルヘキサヒドロ-1H-アゼピン](/CAS/GIF/61771-18-4.gif) |
4-[1-(4-クロロフェニル)-1-フェニルエトキシ]-1-メチルヘキサヒドロ-1H-アゼピン |
61771-18-4 |
C21H26ClNO |
 |
1,4-ジヒドロ-2,6-ジメチル-4-(3-ニトロフェニル)-3,5-ピリジンジカルボン酸3-(2-ヒドロキシエチル)5-イソプロピル |
82219-47-4 |
C20H24N2O7 |
![3-[(3-トリフルオロメチル)フェニル]-1-プロペン](/CAS/GIF/1813-96-3.gif) |
3-[(3-トリフルオロメチル)フェニル]-1-プロペン |
1813-96-3 |
C10H9F3 |
![(AS)-A-(2-CHLOROPHENYL)-2,3,6,7-TETRAHYDRO-2-OXO-THIENO[3,2-C]PYRIDINE-5(4H)-ACETIC ACID METHYL ESTER](/CAS/GIF/527687-26-9.gif) |
(AS)-A-(2-CHLOROPHENYL)-2,3,6,7-TETRAHYDRO-2-OXO-THIENO[3,2-C]PYRIDINE-5(4H)-ACETIC ACID METHYL ESTER |
527687-26-9 |
C16H16ClNO3S |
 |
6-デオキシペンシクロビル |
104227-86-3 |
C10H15N5O2 |
![1,4,8,11-Tetrakis[(4-methylphenyl)sulfonyl]-1,4,8,11-tetraazacyclotetradecane](/CAS2/GIF/71089-74-2.gif) |
1,4,8,11-Tetrakis[(4-methylphenyl)sulfonyl]-1,4,8,11-tetraazacyclotetradecane |
71089-74-2 |
C38H48N4O8S4 |
 |
3-Cyano-4-isobutoxybenzoic acid |
528607-60-5 |
C12H13NO3 |
 |
REF DUPL: trans-2-Hydroxymethyl-5-(cytosin-1-yl)-1,3-oxathiolane |
139757-68-9 |
C8H11N3O3S |
 |
2-(4-モルホリノ-1,2,5-チアジアゾール-3-イルオキシ)-3-(tert-ブチルアミノ)-1-プロパノール |
59697-06-2 |
C13H24N4O3S |
 |
rac Cetirizine N-Oxide > 70% by HPLC
(Mixture of Diastereomers) |
1076199-80-8 |
C21H25ClN2O4 |
 |
(S)-N-Didemethyl Dapoxetine |
147199-40-4 |
C19H19NO |
 |
Hydroxy Flunarizine |
87166-81-2 |
C26H26F2N2O |
 |
1-METHYL-4-NITRO-3-PROPYL-1H-PYRAZOLE-5-CARBOXYLIC ACID |
139756-00-6 |
C8H11N3O4 |
 |
6-Hydroxy Nicorandil |
113743-17-2 |
C8H9N3O5 |
 |
TRANS-イトラコナゾール |
252964-65-1 |
C35H38Cl2N8O4 |
 |
N-(2-Pyridyl)oxamic Acid |
13120-39-3 |
C7H6N2O3 |
 |
(trans)-4-Propyl-1-methyl-L-proline |
13380-36-4 |
C9H17NO2 |
 |
N-Nordextromethorphan
|
1531-23-3 |
C17H23NO |
 |
(S,S,R,R)-オリスタット |
111466-62-7 |
C29H53NO5 |
 |
17β-Carboxy-17-desoxy Dexamethasone |
75262-69-0 |
C21H27FO4 |
 |
1-(dimethoxymethyl)-3-methoxybenzene |
59276-28-7 |
C10H14O3 |
 |
Benazepril impurity A |
|
C24H28N2O5 |
![3S,4R-4-[phenyl-1-methylpiperidinyl] methanol](/CAS/20180906/GIF/176022-03-0.gif) |
3S,4R-4-[phenyl-1-methylpiperidinyl] methanol |
176022-03-0 |
C13H19NO |
![トルセミド関連化合物B (N-[(N-ブチルアミノ)カルボニル]-4-[(3-メチルフェニル)アミノ]-3-ピリジンスルホンアミド)](/CAS/GIF/160972-33-8.gif) |
トルセミド関連化合物B (N-[(N-ブチルアミノ)カルボニル]-4-[(3-メチルフェニル)アミノ]-3-ピリジンスルホンアミド) |
160972-33-8 |
C17H22N4O3S |
 |
(R)-N-DeMethyl Dapoxetine |
1202160-36-8 |
C20H21NO |
![Budesonide Related Compound E (16alpha,17-[butylidenebis(oxy)]-11Beta,21-dihydroxypregna-1,4,14-triene-3,20-dione)](/CAS/GIF/131918-64-4.gif) |
Budesonide Related Compound E (16alpha,17-[butylidenebis(oxy)]-11Beta,21-dihydroxypregna-1,4,14-triene-3,20-dione) |
131918-64-4 |
C25H32O6 |
 |
2-(ベンジルメチルアミノ)-3',4'-ジヒドロキシアセトフェノン |
36467-25-1 |
C16H17NO3 |
 |
2'-O-(5'-Deoxy-β-D-ribofuranosyl) Capecitabine |
1262133-66-3 |
C20H30FN3O9 |
 |
4-Defluoro-4-hydroxy Gefitinib |
847949-50-2 |
C22H25ClN4O4 |
 |
Desethyl Sildenafil |
139755-91-2 |
C20H26N6O4S |
 |
N-Desisopropyl-N-forMyl Bisoprolol |
1346602-59-2 |
C16H25NO5 |
 |
N-DesMethyl Olopatadine |
113835-92-0 |
C20H21NO3 |
 |
TiMolol IMpurity E |
1026075-53-5 |
C17H26N4O6S |
 |
EthanediaMide iMpurity J |
|
C2H4N2O2 |
 |
2-(プロピルチオ)-4,6-ジクロロピリミジン |
1401318-10-2 |
C7H8Cl2N2S |
 |
Istradefylline impurity B |
|
|
 |
Ticagrelor diastereoMer |
1459719-81-3 |
C9H9F2N |
 |
Mirabegron iMpurity |
1581285-26-8 |
C16H21ClN2 |
 |
Sunitinib iMpurity |
356068-98-9 |
C12H19N3O2 |
 |
(-)-ジヒドロビンポセチン |
57327-92-1 |
C22H28N2O2 |
 |
Vildagliptin Related Compound H |
2253194-13-5 |
C12H16N4O |
|
|
Moxifloxacin Impurity 7 |
|
|
![(R)-6-Benzyloxy-8-(oxiran-2-yl)-4H-benzo[1,4]oxazin-3-one](/CAS/20180703/GIF/869478-12-6.gif) |
(R)-6-Benzyloxy-8-(oxiran-2-yl)-4H-benzo[1,4]oxazin-3-one |
869478-12-6 |
C17H15NO4 |
 |
Merariveron impurity D |
|
C26H28N6O3S2 |
|
|
Cefazolin impurity E |
|
|
|
|
Lamivudine Impurity Mixture |
|
|
 |
Rifaximin impurity B |
1351775-04-6 |
C43H49N3O11 |
 |
4-(3-(Piperidin-1-yl)propoxy)benzoic acid |
767286-87-3 |
C15H21NO3 |
 |
5-Chloro-3-sulfino-2-thiophenecarboxylic acid |
187746-97-0 |
C5H3ClO4S2 |
 |
D,L N,O-Didesmethylvenlafaxine |
135308-74-6 |
C15H23NO2 |
 |
Desmethyl Erlotinib Acetate |
183320-15-2 |
C23H23N3O5 |
 |
1',15-オキシエリスロマイシン |
41451-91-6 |
C37H65NO14 |
 |
3,4-ジヒドロキシベンゼンアセトアルデヒド |
5707-55-1 |
C8H8O3 |
 |
9-(2-プロペニル)アデニン |
4121-39-5 |
C8H9N5 |
 |
N-Methyl-N,N-bis(2-pyridylethyl)amine |
5452-87-9 |
C15H19N3 |
|
|
Benazepril Related Compound F |
|
|
![1,5-Benzothiazepin-4(5H)-one, 3-(acetyloxy)-5-[2-(dimethylamino)ethyl]-2,3-dihydro-2-(4-methoxyphenyl)-, (2S-trans)-](/CAS/GIF/111188-70-6.gif) |
1,5-Benzothiazepin-4(5H)-one, 3-(acetyloxy)-5-[2-(dimethylamino)ethyl]-2,3-dihydro-2-(4-methoxyphenyl)-, (2S-trans)- |
111188-70-6 |
C22H26N2O4S |
 |
1H-Benzimidazole-2-sulfinicacid(9CI) |
58536-71-3 |
C7H6N2O2S |
 |
3-メチルフタリド |
3453-64-3 |
C9H8O2 |
 |
4-hydroxyurapidil |
88733-12-4 |
C20H29N5O4 |
 |
desisopropylprocaterol |
63483-95-4 |
C13H16N2O3 |
 |
10-ブロモカルバマゼピン |
59690-97-0 |
C15H11BrN2O |
 |
(-)-アポビンカミン酸エチル |
42971-12-0 |
C22H26N2O2 |
![4-[2-ヒドロキシ-3-[(1-メチルエチル)アミノ]プロポキシ]ベンゼンプロパン酸](/CAS/GIF/81148-15-4.gif) |
4-[2-ヒドロキシ-3-[(1-メチルエチル)アミノ]プロポキシ]ベンゼンプロパン酸 |
81148-15-4 |
C15H23NO4 |
![5-メチル-6-オキソ-5,6-ジヒドロ-4H-イミダゾ[1,5-a][1,4]ベンゾジアゼピン-3-カルボン酸エチル](/CAS/GIF/78756-03-3.gif) |
5-メチル-6-オキソ-5,6-ジヒドロ-4H-イミダゾ[1,5-a][1,4]ベンゾジアゼピン-3-カルボン酸エチル |
78756-03-3 |
C15H15N3O3 |
 |
4-(2-Cyanophenyl)benzaldehyde |
135689-93-9 |
C14H9NO |
 |
2,4-ジクロロ-6-(ジメチルアミノ)-1,3,5-トリアジン |
2401-64-1 |
C5H6Cl2N4 |
 |
(S)-4-Chloro-1,3-butanediol |
139013-68-6 |
C4H9ClO2 |
 |
6-CHLORO-1-METHYLURACIL |
31737-09-4 |
C5H5ClN2O2 |
 |
2-ニトロ-4,5-ビス(2-メトキシエトキシ)安息香酸メチル |
179688-26-7 |
C15H21NO8 |
 |
メタンスルホン酸ヘキシル |
16156-50-6 |
C7H16O3S |
![ethyl (S)-10-fluoro-3-methyl-7-oxo- 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylate](/CAS/20180703/GIF/431058-46-7.gif) |
ethyl (S)-10-fluoro-3-methyl-7-oxo- 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylate |
431058-46-7 |
C15H14FNO4 |
 |
methyl (Z)-3-(((4-(methylamino)phenyl)amino)(phenyl)methylene)-2-oxoindoline-6-carboxylate |
|
C24H21N3O3 |
 |
Isavuconazole Impurity 11 |
2732924-99-9 |
C10H16ClN3O2 |
 |
Levosimendan Impurity 2 |
103416-88-2 |
C11H12N2O2 |
 |
Famotidine EP Impurity A |
88061-72-7 |
C8H15N7O2S3 |
 |
Meloxicam EP Impurity D |
1331636-17-9 |
C16H17N3O4S2 |
 |
Erythromycin Impurity |
40554-78-7 |
C37H65NO12 |
 |
Fluconazole EP Impurity I |
150168-54-0 |
C13H14BrF2N7O |
 |
1-benzyl-2-methyl-1H-imidazole-carbaldehyde |
39269-74-4 |
C12H12N2O |
 |
Sacubitril Impurity |
1015037-46-3 |
C23H27NO4 |
 |
Desloratadine Impurity |
50603-12-8 |
C20H21N |
|
|
Olaparib Impurity H |
|
|
|
|
Brexpiprazole Impurity B |
|
|
|
|
Dapoxetine iMpurity 6 |
|
|
 |
Irbesartan Impurity 4 |
|
C25H28N6O |
 |
2-cyclopentylidene-2-phenylacetic acid |
|
C13H14O2 |
|
|
Cabozantinib impurity B |
|
|
 |
Metoprolol IMpurity 3 |
|
C15H25NO3 |
|
|
Mirabegron Impurity 1 |
|
|
 |
Desfluoro Pitavastatin Calcium |
847849-67-6 |
C25H25NO4 |
 |
Plerixafor |
548488-49-9 |
C12H23F3N4O |
|
|
Vonoprazan Impurity 10 |
|
|
|
|
Vonoprazan Impurity 5 |
|
|
|
|
Sitagliptin IMpurity 1 |
|
|